S
SeqOne
Biotech & Life Sciences · Montpellier, France · Founded 2017
Improving patient outcome by making improved genomic analysis accessible to all MoreLess
SeqOne provides a genomic analysis platform for healthcare providers and molecular laboratories. The company's platform is designed to assist in the treatment of cancer, as well as rare and hereditary diseases, by analyzing next-generation sequencing (NGS) data.
The platform utilizes artificial intelligence and proprietary machine learning algorithms to interpret genomic data, identify genetic variants, and provide decision-support tools to clinicians. This is intended to streamline the diagnostic process and support the delivery of personalized medicine. The SeqOne Platform is a CE-IVD marked in vitro diagnostic medical device.
The company collaborates with other entities in the genomics space, such as Agilent and MGI Tech, to create integrated workflows, for example in liquid biopsy data analysis. SeqOne has secured significant funding, including a €20 million Series A round, to support the expansion and development of its platform.
Keywords: genomic analysis, personalized medicine, oncology, rare diseases, bioinformatics, next-generation sequencing, clinical diagnostics, medical device, data analysis, molecular labs
Company overview
SeqOne company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Montpellier, France
- Employees
- 115
- Open positions
- None listed
- Dealroom signal
- 87.5
- Investment activity
- 2 companies · latest Sep 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
SeqOne funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $22M | $88M | Omnes Capital · Supernova Invest · Elaia · Mérieux Equity Partners | ↗ |
| SERIES A✓Equity / VC | Jan 2022 | $22M | $88M | Irdi Capital Investissement · Elaia · Omnes Capital · Mérieux Equity Partners | ↗ |
| GRANT✓Other financing | Mar 2019 | $0 | — | Undisclosed | — |
| EARLY VC✓Equity / VC | Mar 2019 | $3.3M | $13M | Bpifrance · Irdi Capital Investissement · Elaia | ↗ |
| SPINOUT✓Other financing | Apr 2017 | $0 | — | INSERM · University of Montpellier · SATT AxLR | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
SeqOne website traffic
Latest recorded traffic for SeqOne is 8.9K monthly website visits, down 11% over the last three months. SeqOne's team grew 12.7% over the past year.
Comparisons
SeqOne compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
SeqOne investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
CongenicaHinxton, United KingdomClinical genomics analytics platform
$200Mvaluation
Life & SoftLe Plessis-Robinson, France
→
Talent graph
SeqOne's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where SeqOne has talent and traffic
team presence
In the news
Latest news about SeqOne
Recent press, funding announcements, and product moves mentioning SeqOne — open to read from the original sources.
Market sentiment
What the market is saying about SeqOne
An AI-synthesized read of the highest-engagement posts about SeqOne on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SeqOne’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.